Neoplasma. 2018;65(1):49-54. doi: 10.4149/neo_2018_170306N159.
Breast cancer is one of the most prevalent and fatal diseases around the world. The mechanism of tumorigenesis in breast cancer remains to be clarified. miR-421 plays an oncogenic role in many cancers. Although, the clinical significance of miR-421 in patients with breast cancer is still to be investigated. Caspase-10 is one of the initiator of apoptosis. But the relationship between miR-421 and caspase-10 has not been investigated. In the present study, we found that miR-421 was expressed much higher in breast cancer tissues compared to those in adjacent non-tumor tissues. Furthermore, miR-421 promotes cell proliferation and colony formation in vitro. miR-421 inhibits cell apoptosis probably through restraining caspase-10 expression. Thus, miR-421 might be a potential diagnostic maker and therapeutic target for breast cancer.
乳腺癌是全球最普遍和致命的疾病之一。乳腺癌的肿瘤发生机制仍有待阐明。miR-421 在许多癌症中发挥致癌作用。尽管如此,miR-421 在乳腺癌患者中的临床意义仍有待研究。Caspase-10 是凋亡的起始因子之一。但是,miR-421 和 caspase-10 之间的关系尚未被研究。在本研究中,我们发现与相邻非肿瘤组织相比,乳腺癌组织中 miR-421 的表达水平明显更高。此外,miR-421 可促进体外细胞增殖和集落形成。miR-421 通过抑制 caspase-10 的表达来抑制细胞凋亡。因此,miR-421 可能是乳腺癌的一个有潜力的诊断标志物和治疗靶点。